Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics. We strive to build an enduring innovation engine built on strong scientific execution, high value analytics and aggressive portfolio management.

A robust mix of internal ideation and strategic partnering with academic innovators and bio-pharma entrepreneurs fuel our engine with potentially high impact ideas. We partner with thought-leading clinicians across the world for ideas and access. Innovation through integration of partner knowledge and efficient internal execution shapes our future. Our aim is to consistently lower costs and improve operational efficiencies to advance availability and affordability of cures for patients across the world. We realize our dream when we help patients lead more fulfilling lives.

SPARC is a vibrant innovation community spread over three locations globally. We endeavour to develop a meritocracy which takes pride in continuous learning and re-invention. Our aspiration hinges on creating a culture which can attract high quality talent globally, develop them into passionate drug developers & creative problem solvers and empower them with a smart toolset. We are committed to our pursuit of excellence.

SPARC is a responsible public company committed to maintaining highest standards of ethics and transparency. Our accountability to patients we seek to serve and investors who enable us and our commitment to sustainable human progress are key components of our identity – A responsible innovator inspired by life’s amazing ability to learn, evolve and survive. We exist because we seek to be part of the solution.